Cofactor Genomics, a clinical-stage company focused on RNA analysis for precision medicine, has received national coverage from Medicare contractor...

Vertex Pharmaceuticals will unveil its pivotal Phase 3 data for suzetrigine, a potential non-opioid treatment for moderate-to-severe acute pain,...

Gilead Sciences and Merck have announced positive results from a Phase 2 clinical trial investigating a novel combination therapy...

Merck, known as MSD outside of the United States and Canada, announced positive results from their Phase 2b/3 clinical...

Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has successfully produced Actinium-225 (Ac-225) by irradiating...

A recent virtual summit hosted by Cyntegrity focused on the pivotal role of artificial intelligence (AI) in Risk-Based Quality...

Response Pharmaceuticals, a clinical-stage company specializing in weight management and metabolic health, has begun enrolling participants in a Phase...

Terray Therapeutics, a biotechnology company revolutionizing small molecule drug development, has secured $120 million in Series B funding. This...

Verastem Oncology, a company dedicated to developing cancer treatments, has released promising data from its Phase 2 RAMP 201...

Clinical laboratories face a critical deadline: achieving Phase One compliance with the FDA’s Laboratory Developed Test (LDT) rule by...